eMedicine Specialties > Pulmonology > Infectious Lung Diseases
Pneumonia, Bacterial: Multimedia
Updated: Feb 12, 2007
Multimedia
 | Media file 1: Bacterial pneumonia. Lung specimen from a patient who died from severe Klebsiella pneumonia. |
 | Media file 2: Bacterial pneumonia. Pneumococci on sputum Gram stain. |
 | Media file 3: Bacterial pneumonia. Histopathological micrograph of bacterial pneumonia showing extensive infiltration with inflammatory cells. |
 | Media file 4: Bacterial pneumonia. Sputum Gram stain is performed prior to culture. An inadequate specimen contains more than 25 epithelial cells per high-power field. |
 | Media file 5: Bacterial pneumonia. Numerous pus cells indicate an adequate specimen that should be cultured. |
 | Media file 6: Bacterial pneumonia. Haemophilus influenzae on sputum culture. |
 | Media file 7: Bacterial pneumonia. Klebsiella pneumoniae on sputum Gram stain. |
 | Media file 8: Legionella pneumophila on Gram stain of lung tissue obtained by open lung biopsy. |
 | Media file 9: Bacterial pneumonia. Bilateral airspace infiltration secondary to community-acquired pneumonia, subsequently confirmed to be Legionella pneumonia. |
 | Media file 10: Bacterial pneumonia. Rarely, severe pneumococcal infection may be associated with necrotizing pneumonia. |
 | Media file 11: Bacterial pneumonia. A posteroanterior chest radiograph shows left lower pneumonia. Sputum Gram stain showed gram-positive diplococci. |
 | Media file 12: Bacterial pneumonia. Lateral chest radiograph of a patient with left lower pneumonia. Sputum Gram stain showed gram-positive diplococci. |
 | Media file 13: Bacterial pneumonia. Chest radiographs showing right middle lobe pneumonia. |
 | Media file 14: Bacterial pneumonia. Right upper lobe lobar pneumonia secondary to Streptococcus pneumoniae infection. |
 | Media file 15: Bacterial pneumonia. Hospital-acquired right lower lobe pneumonia; sputum culture confirmed this to be secondary to gram-negative organisms. |
 | Media file 16: Bacterial pneumonia. Postobstructive right lower lobe pneumonia and an associated pleural effusion. There is loss of volume of right hemithorax, shift of trachea and mediastinum to the right. |
 | Media file 17: Bacterial pneumonia. Bilateral pneumococcal pneumonia in a patient who is an intravenous drug user but does not have HIV infection. |
 | Media file 18: CT scan of a patient not infected with HIV who has Pneumocystis carinii pneumonia. |
 | Media file 19: Chest radiograph of a patient not infected with HIV who has Pneumocystis carinii pneumonia. |
More on Pneumonia, Bacterial |
| Overview: Pneumonia, Bacterial |
| Differential Diagnoses & Workup: Pneumonia, Bacterial |
| Treatment & Medication: Pneumonia, Bacterial |
| Follow-up: Pneumonia, Bacterial |
 Multimedia: Pneumonia, Bacterial |
| References |
| « Previous Page |
References
Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. Feb 1999;13(2):349-55. [Medline].
Aspa J, Rajas O, Rodriguez de Castro F, Huertas MC, Borderias L, Cabello FJ, et al. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J. May 2006;27(5):1010-9. [Medline].
Balleste CR, Gonzalez G, Ramirez-Ronda CH, Saavedra S, Alvarez L, Arroyo E, et al. Potentially serious infections in the aging person: diagnosis, treatment and prevention. P R Health Sci J. Mar 2004;23(1):19-24. [Medline].
Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. Dec 14 1995;333(24):1618-24. [Medline].
Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis. Apr 1998;26(4):811-38. [Medline].
Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. May 2006;61(5):419-24. [Medline].
Carratala J, Martín-Herrero JE, Mykietiuk A, Garcia-Rey C. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Clin Microbiol Infect. May 2006;12 Suppl 3:2-11. [Medline].
Carrie AG, Kozyrskyj AL. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones. Can J Clin Pharmacol. 2006;13(1):e102-11. [Medline].
Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. Apr 1998;157(4 Pt 1):1165-72. [Medline].
Coope R. Diseases of the Chest. Edinburgh, UK: E&S Livingstone; 1944.
Corley DE, Kirtland SH, Winterbauer RH, Hammar SP, Dail DH, Bauermeister DE, et al. Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists: analysis of a gold standard. Chest. Aug 1997;112(2):458-65. [Medline].
Craven DE, Steger KA, Barber TW. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med. Sep 16 1991;91(3B):44S-53S. [Medline].
Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest. Aug 1995;108(2 Suppl):1S-16S. [Medline].
Crnich CJ, Proctor RA. Treatment of pneumococcal pneumonia: what's in an MIC?. Crit Care Med. Mar 2004;32(3):876-8. [Medline].
Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. May 2006;12 Suppl 3:12-24. [Medline].
Davydov L, Ebert SC, Restino M, Gardner M, Bedenkop G, Uchida KM, et al. Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals. Diagn Microbiol Infect Dis. Apr 2006;54(4):267-75. [Medline].
Depuydt P, Myny D, Blot S. Nosocomial pneumonia: aetiology, diagnosis and treatment. Curr Opin Pulm Med. May 2006;12(3):192-7. [Medline].
Domínguez AA, Arango MV, Torres A. Treatment failure in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med. Feb 2006;27(1):104-14. [Medline].
Fagon J, Patrick H, Haas DW, Torres A, Gibert C, Cheadle WG, et al. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. Am J Respir Crit Care Med. Mar 2000;161(3 Pt 1):753-62. [Medline].
Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. Mar 1993;94(3):281-8. [Medline].
Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. Feb 2000;90(2):223-9. [Medline].
Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. Jan 10 1996;275(2):134-41. [Medline].
Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. May 10 1999;159(9):970-80. [Medline].
Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. Jun 28 1985;78(6B):32-7. [Medline].
Glasser F, Fein AM, Feinsilver SH, Cotton E, Niederman MS. Non-cardiogenic pulmonary edema after pericardial drainage for cardiac tamponade. Chest. Oct 1988;94(4):869-70. [Medline].
Glasser F, Fein AM, Feinsilver SH. Non-cardiogenic pulmonary edema after pericardial drainage for cardiac tamponade. Chest. Oct 1988;94(4):869-70. [Medline].
Griffin JJ, Meduri GU. New approaches in the diagnosis of nosocomial pneumonia. Med Clin North Am. Sep 1994;78(5):1091-122. [Medline].
Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. Nov 1989;87(5):540-6. [Medline].
Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest. Dec 1998;114(6):1588-93. [Medline].
Kirtland SH, Corley DE, Winterbauer RH, Springmeyer SC, Casey KR, Hampson NB, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest. Aug 1997;112(2):445-57. [Medline].
Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. Feb 1998;113(2):412-20. [Medline].
Kollef MH, Micek ST. Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen?. Curr Opin Infect Dis. Apr 2006;19(2):161-8. [Medline].
Lednicky JA, Rayner JO. Uncommon respiratory pathogens. Curr Opin Pulm Med. May 2006;12(3):235-9. [Medline].
Lutfiyya MN, Henley E, Chang LF, Reyburn SW. Diagnosis and treatment of community-acquired pneumonia. Am Fam Physician. Feb 1 2006;73(3):442-50. [Medline].
Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect. Sep 1999;14(3):227-36. [Medline].
Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. Feb 9 2000;283(6):749-55. [Medline].
Marshall DA, McGeer A, Gough J. Impact of antibiotic administrative restrictions on trends in antibiotic resistance. Can J Public Health. Mar-Apr 2006;97(2):126-31. [Medline].
Marshall DA, McGeer A, Gough J, Grootendorst P, Buitendyk M, Simonyi S, et al. Impact of antibiotic administrative restrictions on trends in antibiotic resistance. Can J Public Health. Mar-Apr 2006;97(2):126-31. [Medline].
Meduri GU, Johanson WG Jr. International Consensus Conference: clinical investigation of ventilator-associated pneumonia. Introduction. Chest. Nov 1992;102(5 Suppl 1):551S-552S. [Medline].
Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006;45(7):419-28. [Medline].
Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of empiric antimicrobial therapy with a beta-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Crit Care. Dec 6 2005;10(1):R8. [Medline].
Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. Nov 1993;148(5):1418-26. [Medline].
Niederman MS. An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am. Sep 1994;78(5):1123-41. [Medline].
Niederman MS. Community-acquired pneumonia: a North American perspective. Chest. Mar 1998;113(3 Suppl):179S-182S. [Medline].
Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med. Dec 2005;26(6):563-74. [Medline].
Read RC. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia. J Infect. Nov 1999;39(3):171-8. [Medline].
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. Aug 2006;28(2):346-51. [Medline].
Salluh JI, Verdeal JC, Mello GW, Araújo LV, Martins GA, de Sousa Santino M, et al. Cortisol levels in patients with severe community-acquired pneumonia. Intensive Care Med. Apr 2006;32(4):595-8. [Medline].
de Roux A, Cavalcanti M, Marcos MA, Garcia E, Ewig S, Mensa J, et al. Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest. May 2006;129(5):1219-25. [Medline].
Further Reading
Keywords
pneumonia, pneumococcus, Streptococcus pneumoniae, S pneumoniae, Haemophilus influenzae, H influenzae, Staphylococcus aureus, S aureus, Legionella, Legionella pneumophila, Mycoplasma, Mycoplasma pneumoniae, Chlamydia psittaci, Coccidioides immitis, Mycobacterium tuberculosis, M tuberculosis, Histoplasmacapsulatum, Coxiella burnetii, C burnetii, Burkholderia pseudomallei, Pseudomonas, Pseudomonas pseudomallei, Melioidosis, Klebsiella, Klebsiella pneumoniae, K pneumoniae, Moraxella catarrhalis, M catarrhalis, Pneumocystis carinii, Cryptococcus neoformans, Rhodococcus equi, Mycobacterium avium-intracellulare, Serratia marcescens, Nocardia, Escherichia coli, Enterobacter, Serratia species, Bacteroides, Peptostreptococcus, Fusobacterium species, hospital-acquired pneumonia, community-acquired pneumonia, CAP, nosocomial pneumonia, viral pneumonia, typical pneumonia, atypical pneumonia, lobular pneumonia, lobar pneumonia, bronchial pneumonia
